cisplatin,pemetrexed,pembrolizumab,gemcitabine
merck
['lung', 'lcsm,(-blcsm)', 'keynote,671', 'keynote-671', 'ts,perio,i', 'pembro', 'nsclc', 'sclc', 'ts,perio,1']
perioperative pembrolizumab regimen improves efs outcomes for patients with early-stage nsclc, according to findings from keynote-671. #asco23 #lcsm #lungcancer #oncology #nursing #nsclc 
Capturing the voice of nursing professionals in the oncology news landscape.